Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -48.944% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CSc1n[nH]c(-c2sccc2OCc2ccc(C)cc2)n1
b COc1ccccc1CNC(=O)COC(=O)c1cc([N+](=O)[O-])ccc1N1CCOCC1
Answer: b. COc1ccccc1CNC(=O)COC(=O)c1cc([N+](=O)[O-])ccc1N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1CNC(=O)COC(=O)c1cc([N+](=O)[O-])ccc1N1CCOCC1
COc1ccccc1CNC(=O)COC(=O)c1cc([N+](=O)[O-])ccc1N1CCOCC1
[2-[(2-methoxyphenyl)methylamino]-2-oxoethyl] 2-morpholin-4-yl-5-nitrobenzoate